290 related articles for article (PubMed ID: 35569946)
41. An overlap of granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis.
Surendran S; Gundappa C; Gandhi A; Kurien AA; Fernando E
Saudi J Kidney Dis Transpl; 2017; 28(3):639-644. PubMed ID: 28540906
[TBL] [Abstract][Full Text] [Related]
42. Familial Eosinophilic Granulomatosis with Polyangiitis in a Sister and Brother.
Ueki Y; Oshikata C; Asai Y; Kaneko T; Tsurikisawa N
Intern Med; 2020 Apr; 59(7):991-995. PubMed ID: 31813915
[TBL] [Abstract][Full Text] [Related]
43. When inflammation is not just inflammation-A review of systemic diseases of the nose and sinuses part 2: Granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis.
Cler SJ; Ogden MA; Farrell NF; Roland LT; Diffie CE; Schneider JS
Am J Otolaryngol; 2024; 45(3):104207. PubMed ID: 38176206
[TBL] [Abstract][Full Text] [Related]
44. Eosinophilic granulomatosis with polyangiitis associated with abducens nerve palsy.
Toma C; Sindaco D; Musolino M; Traverso CE; Iester M; Vagge A
J AAPOS; 2022 Dec; 26(6):333-336. PubMed ID: 36182029
[TBL] [Abstract][Full Text] [Related]
45. [Eosinophilic small vessel vasculites (EGPA) a hidden severe asthma comorbitity].
Sturluson OO; Palsson O; Hjaltested E; Ludviksdottir D
Laeknabladid; 2024 Jan; 110(1):28-32. PubMed ID: 38126794
[TBL] [Abstract][Full Text] [Related]
46. ANCA-negative eosinophilic granulomatosis with polyangiitis complicated by peripheral nerve damage: A case report.
Chen Y; Wan Q; Liu B
Medicine (Baltimore); 2023 Aug; 102(31):e34450. PubMed ID: 37543822
[TBL] [Abstract][Full Text] [Related]
47. Mepolizumab for the treatment of eosinophilic granulomatosis with polyangiitis.
McBrien CN; Menzies-Gow A
Drugs Today (Barc); 2018 Feb; 54(2):93-101. PubMed ID: 29637936
[TBL] [Abstract][Full Text] [Related]
48. Efficacy of Benralizumab and Clinical Course of IgG4 in Eosinophilic Granulomatosis With Polyangiitis.
Miyata Y; Inoue H; Homma T; Tanaka A; Sagara H
J Investig Allergol Clin Immunol; 2021 Jul; 31(4):346-348. PubMed ID: 33030432
[No Abstract] [Full Text] [Related]
49. Acute Cholecystitis Associated with Eosinophilic Granulomatosis with Polyangiitis That Responded to Glucocorticoid Therapy.
Ozaka S; Kodera T; Tsutsumi K; Fukuda M; Iwao M; Hirashita Y; Takahashi H; Fukuda K; Okamoto K; Arakawa M; Ogawa R; Endo M; Mizukami K; Okimoto T; Kamiyama N; Kodama M; Kobayashi T; Murakami K
Intern Med; 2023 May; 62(10):1501-1506. PubMed ID: 36171126
[TBL] [Abstract][Full Text] [Related]
50. Case Report: Severe Eosinophilic Asthma Associated With ANCA-Negative EGPA in a Young Adult Successfully Treated With Benralizumab.
Ricciardi L; Soler DG; Bennici A; Brunetto S; Pioggia G; Gangemi S
Front Pharmacol; 2022; 13():858344. PubMed ID: 35462932
[No Abstract] [Full Text] [Related]
51. Negative anti-neutrophil cytoplasmic antibodies and eosinophilic granulomatosis with polyangiitis accompanied by cough variant asthma: a case report.
Li Y; Chen Z; Zhu S; Bai F; Liu Y; Gao L; Li X; Geng Y; Zhang G
Ann Palliat Med; 2021 Oct; 10(10):11209-11215. PubMed ID: 34763478
[TBL] [Abstract][Full Text] [Related]
52. Evaluation of prognostic factors for patients with eosinophilic granulomatosis with polyangiitis recruited at the pneumonological centre and mainly ANCA negativity: A retrospective analysis of a single cohort in Poland.
Fijolek J; Wiatr E; Bujnowski P; Piotrowska-Kownacka D; Roszkowski-Sliz K
Mod Rheumatol; 2023 Dec; 34(1):157-166. PubMed ID: 36658715
[TBL] [Abstract][Full Text] [Related]
53. Benralizumab monotherapy was insufficient to induce remission in patients with active eosinophilic granulomatosis with polyangiitis.
Matsuno O; Minamoto S
Respir Med Case Rep; 2022; 40():101763. PubMed ID: 36353062
[TBL] [Abstract][Full Text] [Related]
54. Use of IL-5 Inhibitor Benralizumab as a Novel Therapy for Eosinophilic Otitis Media: Clinical Capsule and Review of Literature.
Chow K; Cosetti MK
Otol Neurotol; 2020 Feb; 41(2):e238-e240. PubMed ID: 31923159
[TBL] [Abstract][Full Text] [Related]
55. Severe/uncontrolled asthma and overall survival in atopic patients with eosinophilic granulomatosis with polyangiitis.
Berti A; Volcheck GW; Cornec D; Smyth RJ; Specks U; Keogh KA
Respir Med; 2018 Sep; 142():66-72. PubMed ID: 30170804
[TBL] [Abstract][Full Text] [Related]
56. Successful treatment of eosinophilic otitis media associated with severe bronchial asthma with an anti-IL-5 monoclonal antibody, mepolizumab.
Suzaki I; Kimura Y; Tanaka A; Hirano K; Ishibashi A; Mizuyoshi T; Ando I; Kitajima T; Watanabe S; Hinohira Y; Kobayashi H
Auris Nasus Larynx; 2019 Feb; 46(1):141-146. PubMed ID: 29909018
[TBL] [Abstract][Full Text] [Related]
57. Perspectives on the Efficacy of Benralizumab for Treatment of Eosinophilic Granulomatosis With Polyangiitis.
Koga Y; Aoki-Saito H; Kamide Y; Sato M; Tsurumaki H; Yatomi M; Ishizuka T; Hisada T
Front Pharmacol; 2022; 13():865318. PubMed ID: 35359852
[TBL] [Abstract][Full Text] [Related]
58. A delayed diagnosis of eosinophilic granulomatosis with polyangiitis complicated with extensive artery occlusion of lower extremities in children: case report and literature review.
Liu X; Wang L; Zhou K; Hua Y; Shi X; Wang C
Pediatr Rheumatol Online J; 2019 May; 17(1):26. PubMed ID: 31138304
[TBL] [Abstract][Full Text] [Related]
59. Eosinophilic granulomatosis with polyangiitis onset in severe asthma patients on monoclonal antibodies targeting type 2 inflammation: Report from the European EGPA study group.
Caminati M; Fassio A; Alberici F; Baldini C; Bello F; Cameli P; Conticini E; Cottin V; Crimi C; Dagna L; Delvino P; Deroux A; Duran E; Espigol-Frigole G; Karadag O; Maule M; Moiseev S; Monti S; Moroni L; Padoan R; Pugnet G; Taille C; Toniati P; Vaglio A; Emmi G
Allergy; 2024 Feb; 79(2):516-519. PubMed ID: 37904674
[No Abstract] [Full Text] [Related]
60. Response to mepolizumab according to disease manifestations in patients with eosinophilic granulomatosis with polyangiitis.
Ríos-Garcés R; Prieto-González S; Hernández-Rodríguez J; Arismendi E; Alobid I; Penatti AE; Cid MC; Espígol-Frigolé G
Eur J Intern Med; 2022 Jan; 95():61-66. PubMed ID: 34535374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
